Louisiana HR290 requests the Louisiana Department of Health to study the effects of gender-affirming hormone therapy on mental health in individuals.
Louisiana HR290 urges the Louisiana Department of Health to study the potential correlation between medications prescribed for gender-affirming hormone therapy and the incidence of psychosis and related psychiatric conditions in individuals aged 26 and younger. The study will review available medical literature, examine adverse event data, and consult with healthcare professionals. The Department must submit a report with findings and recommendations to the House Committee on Health and Welfare by February 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.